ArticleBMC cancer2025
A novel MRI-based habitat analysis and deep learning for predicting perineural invasion in prostate cancer: a two-center study.
Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- MRI Habitat Analysis for Preoperative Prediction of Perineural Invasion and Prognostic Stratification in Rectal Cancer.Journal of magnetic resonance imaging : JMRI · 2026Article
- Perineural Invasion Worsens Long-Term Outcomes of Pancreatic Neuroendocrine Tumors Following Surgical Resection.Annals of surgical oncology · 2026Article
- Perineural invasion in solid tumors: biological foundations and the emerging integration of machine learning and artificial intelligence.Frontiers in oncology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundTo explore the efficacy of a deep learning (DL) model in predicting perineural invasion (PNI) in prostate cancer (PCa) by conducting multiparametric MRI (mpMRI)-based tumor heterogeneity analysis.
methodsThis retrospective study included 397 patients with PCa from two medical centers. The patients were divided into training, internal validation (in-vad), and independent external validation (ex-vad) cohorts (n = 173, 74, and 150, respectively). mpMRI-based habitat analysis, comprising T2-weighted imaging, diffusion-weighted imaging, and apparent diffusion coefficient sequences, was performed followed by DL, deep feature selection, and filtration to compute a radscore. Subsequently, six models were constructed: one clinical model, four habitat models (habitats 1, 2, 3, and whole-tumor), and one combined model. Receiver operating characteristic curve analysis was performed to evaluate the models' ability to predict PNI.
resultsThe four habitat models exhibited robust performance in predicting PNI, with area under the curve (AUC) values of 0.862-0.935, 0.802-0.957, and 0.859-0.939 in the training, in-vad, and ex-vad cohorts, respectively. The clinical model had AUC values of 0.832, 0.818, and 0.789 in the training, in-vad, and ex-vad cohorts, respectively. The combined model outperformed the clinical and habitat models, with AUC, sensitivity, and specificity values of 0.999, 1, and 0.955 for the training cohort. Decision curve analysis and clinical impact curve analysis indicated favorable clinical applicability and utility of the combined model.
conclusionDL models constructed through mpMRI-based habitat analysis accurately predict the PNI status of PCa.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.